Biotech Showcase™ is an investor and partnering conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.
Biotech Showcase is an investor and partnering conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.
The TERMIS-AM Meeting is the key annual meeting held in the Americas each year, and brings together over 800 researchers, scientists, trainees, and students from both academia and industry to discuss critical developments in the field. The meeting is led by keynote speakers each day, and consists of parallel technical sessions as well as poster presentations. A strong role in the meeting planning and execution will be played by the TERMIS-AM Student and Young Investigator Section (SYIS). Furthermore, there will be an emphasis on promoting the careers of women and underrepresented groups in the tissue engineering and regenerative medicine fields.
The briefing will provide an update on the latest advances moving forward in the field and address how The Regenerative Medicine Promotion Act can remove some of the hurdles facing the field of regenerative medicine.
Please RSVP by Monday, November 10 to Miranda Franco at Miranda.franco@hklaw.com or 202-469-5259.
Poised to bridge the Pacific in regenerative medicine, the 2nd annual WAFSF on “The Impact of Regenerative Medicine 2014” focuses on the status and issues of moving iPSC to clinical applications. A large contingent of top Japanese researchers and businesses will participate, joined by their West Coast counterparts. Use promo code “25OFFARM” for ARM member’s registration discount of $200. Visit www.wafsf.org.
ISSCR and SCSS are proud to present a program designed to explore the fundamental molecular mechanisms controlling cell identity with leaders in ES cell pluripotency, development and cellular reprogramming.
The 20th annual BIO-Europe® event will be the largest biotechnology partnering conference held in Europe. Over 3,000 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
Join AABB and the University of Pennsylvania for a joint workshop titled CAR T Cell Adoptive Therapies: Product Engineering to Clinical Outcomes to be held at the AABB Annual Meeting in Philadelphia, PA!
